南京科佰生物科技有限公司官方网站欢迎您的光临!
免费咨询热线: 4008-750-250
科研细胞
药靶细胞
标准品
NGS靶向捕获探针
HCC1806(人乳腺癌细胞)
CBP60373 | |
I. General information | |
Synonyms: | HCC1806 |
Background: | The HCC1806 breast cancer cell line was initiated on July 31, 1995, and took 10 months to establish. |
Species: | Homo sapiens, human |
Tissue: | mammary gland; breast |
Disease: | TNM stage IIB, grade 2, primary acantholytic squamous cell carcinoma |
Gender: | female, 60 years, Black |
Morphology: | epithelial |
Growth Mode: | adherent, The line grows as attached medium-sized epithelial cells without floating cells. |
DNA Profile: | D5S818: 13 D13S317: 11 D7S820: 10, 12 D16S539: 10 vWA: 16, 18 TH01: 8 Amelogenin: X TPOX: 8, 9 CSF1PO: 12 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI-1640+10%FBS HCC1806完全培养基,# CBP60373M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Receptor Expression: | estrogen receptor, negative progesterone receptor, negative |
Oncogene: | her2/neu -, p53 - |
Genes Expressed: | Epithelial glycoprotein 2 [EGP2]; cytokeratin 19 |
Cellular Products: | Epithelial glycoprotein 2 [EGP2]; cytokeratin 19 |
Comments: | The tumor was classified as a TNM Stage IIB, grade 2, acantholytic squamous carcinoma with no lymph node metastasis. There was no family history of breast cancer. The cells are poorly differentiated. The cells are negative for expression of Her2-neu and for expression of p53. HCC1806 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2) and for cytokeratin 19. The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR). The cells are homozygous for deletions in the FHIT gene at 3p14.2. For more information, please contact Cobioer (4008-750-250). |
扫一扫,关注我们公众号
Copyright ©2021 www.cobioer.com All Rights Reserved. 南京科佰生物科技有限公司版权所有 苏ICP备13038923号